- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2015
- Public Summary Document (PSD) March 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2015 PBAC Meeting - Word
Sorafenib – March 2015
Sorafenib; 200 mg tablet 60; Nexavar®
Last updated
17 July 2015